+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Drug Eluting Sutures Market - Global Forecast 2026-2032- Product Image
Drug Eluting Sutures Market - Global Forecast 2026-2032- Product Image
Sale

Drug Eluting Sutures Market - Global Forecast 2026-2032

  • Report

  • 190 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6122063
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Drug Eluting Sutures Market is projected to reach USD 1.60 Billion in 2026. It is expected to continue growing at a CAGR of 5.59%, reaching USD 2.25 Billion by 2032.

Drug-Eluting Sutures: Executive Overview

Drug-eluting sutures combine mechanical wound approximation with localized delivery of an active pharmaceutical or antimicrobial agent. Their clinical rationale is to support closure while addressing risks such as microbial contamination, inflammation, or impaired healing at the incision site. Adoption depends on demonstrated clinical benefit, biocompatibility, handling performance, regulatory authorization, reimbursement conditions, and compatibility with established surgical workflows.

How Localized Delivery Is Reshaping Surgical Closure

The field is shifting from passive closure materials toward multifunctional products designed to interact with the wound environment. Important developments include controlled release, improved coating adhesion, biodegradable materials, infection-focused formulations, and compatibility with minimally invasive procedures. Evidence requirements are also becoming more demanding: manufacturers and healthcare providers increasingly need to connect laboratory release profiles with clinically meaningful outcomes, while procurement teams assess safety, ease of use, training requirements, and total procedural value.

Artificial Intelligence Strengthens Design, Evidence, and Care Pathways

Artificial intelligence can support drug-eluting suture development by helping researchers screen materials, model release behavior, identify formulation patterns, and prioritize experiments. In clinical and operational settings, analytical tools may assist with risk stratification, wound-monitoring workflows, study recruitment, and post-market signal detection. These applications do not replace prospective validation, clinician judgment, or regulatory review. Data quality, explainability, cybersecurity, privacy, and bias controls remain essential before AI-supported insights influence product claims or patient management.

Regional Insights Across Six Healthcare Environments

North America is characterized by strong surgical infrastructure, sophisticated device evaluation, and close scrutiny of clinical and economic evidence. Europe emphasizes harmonized regulatory and quality requirements alongside country-specific purchasing and reimbursement processes. Asia-Pacific combines advanced markets with rapidly expanding healthcare capacity, creating varied pathways for evidence generation, registration, and adoption. Latin America’s opportunity is linked to improving surgical access and infection prevention, while affordability, procurement consistency, and local regulatory capability remain important. The Middle East is supported by investment in specialist care and hospital modernization, with adoption influenced by centralized purchasing and clinical expertise. Africa presents substantial unmet needs in surgical access and infection control; scalable supply, training, affordability, and resilient distribution are central to responsible implementation.

Group Insights: Trade, Regulation, and Health-System Alignment

ASEAN markets require attention to regulatory coordination, uneven healthcare capacity, and cross-border supply considerations. BRICS members span highly diverse clinical systems, manufacturing capabilities, and approval pathways, making localized evidence and partnership models important. The European Union benefits from a shared regulatory architecture, but national reimbursement and procurement decisions still shape uptake. G7 health systems generally place strong emphasis on clinical evidence, quality systems, patient safety, and value-based purchasing. GCC countries often combine advanced hospitals with centralized or coordinated procurement, increasing the importance of tender readiness and specialist education. NATO members do not form a single healthcare market, yet interoperability, supply resilience, emergency preparedness, and quality assurance can influence institutional priorities across participating countries.

Country Insights: Diverse Routes to Clinical Adoption

Australia emphasizes evidence-based care, centralized therapeutic oversight, and geographically resilient supply. Brazil combines a large public-private healthcare structure with varied regulatory and procurement conditions. Canada’s adoption pathway reflects federal oversight, provincial purchasing, and regional differences in care delivery. China is shaped by hospital modernization, domestic manufacturing capability, and evolving regulatory expectations. France, Germany, Italy, and Spain operate within the European framework while retaining distinct reimbursement, procurement, and clinical practice dynamics. India’s priorities include affordability, surgical scale, local production, and access across unevenly resourced facilities. Japan and South Korea place strong emphasis on quality, safety, advanced hospital practice, and rigorous product evaluation. Mexico’s mixed healthcare system makes distribution, affordability, and institutional procurement important. Russia’s environment is influenced by domestic supply considerations and regulatory complexity. The United Kingdom prioritizes evidence, safety, and health-system value through its distinct post-EU regulatory and procurement context. The United States combines substantial procedural capacity with demanding regulatory, payer, hospital, and evidence requirements.

Actions for Leaders: Prove Benefit, Integrate Workflows, and Build Resilience

Industry leaders should define a narrowly supported clinical use case and generate evidence that measures both safety and meaningful outcomes, such as infection-related endpoints, healing performance, reintervention, handling, and patient experience. Product development should incorporate surgeon feedback, manufacturability, sterilization stability, release consistency, and clear instructions for use from the outset. Commercial teams should map regulatory, reimbursement, and procurement requirements by jurisdiction rather than assume portability of evidence. Partnerships with hospitals, academic investigators, local distributors, and infection-prevention specialists can improve implementation quality. Leaders should also establish traceability, post-market surveillance, cybersecurity controls for connected workflows, and supply plans that reduce dependence on fragile sources of critical materials.

Methodology: Evidence-Led Synthesis of Product, Clinical, and System Factors

This executive summary uses the defined market scope of drug-eluting sutures and organizes the assessment across product characteristics, clinical applications, regulatory considerations, healthcare-system conditions, technology trends, and geographic context. Interpretation should be grounded in peer-reviewed clinical literature, regulatory publications, standards, procurement documentation, hospital practice guidance, and validated technical studies. Regional, group, and country comparisons are qualitative and reflect differences in infrastructure, policy, purchasing, clinical practice, and access. No market estimates, market shares, forecasts, or company-specific claims are used.

Conclusion: Clinical Proof and Practical Delivery Will Determine Progress

Drug-eluting sutures sit at the intersection of surgical materials, local drug delivery, infection prevention, and value-based care. Their long-term relevance will depend less on novelty alone than on reproducible manufacturing, safe release behavior, credible clinical benefit, workflow fit, and equitable access. Organizations that align product design with regulatory evidence, clinician needs, procurement realities, and responsible digital capabilities will be better positioned to translate this technology from specialized development into dependable surgical practice.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Drug Eluting Sutures Market, by Drug Type
7.1. Introduction
7.2. Anti-adhesion Eluting
7.3. Anti-inflammatory Eluting
7.3.1. Nsaid Coated
7.3.2. Steroid Coated
7.4. Antimicrobial Eluting
7.4.1. Silver Coated
7.4.2. Triclosan Coated
7.5. Growth Factor Eluting
7.5.1. Bmp Coated
7.5.2. Vegf Coated
8. Drug Eluting Sutures Market, by Material
8.1. Introduction
8.2. Natural
8.2.1. Catgut
8.2.2. Silk
8.3. Synthetic
8.3.1. Poliglecaprone
8.3.2. Polydioxanone
8.3.3. Polyglactin
9. Drug Eluting Sutures Market, by Application
9.1. Introduction
9.2. Cardiovascular
9.2.1. Bypass Surgery
9.2.2. Valve Repair
9.3. General Surgery
9.3.1. Abdominal Surgery
9.3.2. Plastic Surgery
9.3.3. Urological Surgery
9.4. Gynecology
9.5. Ophthalmic
9.6. Orthopedic
9.6.1. Joint Reconstruction
9.6.2. Sports Medicine
10. Drug Eluting Sutures Market, by End User
10.1. Introduction
10.2. Ambulatory Surgical Centers
10.3. Clinics
10.4. Hospitals
11. Drug Eluting Sutures Market, by Distribution Channel
11.1. Introduction
11.2. Offline
11.3. Online
12. Drug Eluting Sutures Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Drug Eluting Sutures Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Drug Eluting Sutures Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Aesculap AG
16.2. Allergan plc
16.3. AstraZeneca PLC
16.4. B. Braun Melsungen AG
16.5. Becton, Dickinson and Company
16.6. Conmed Corporation
16.7. Cook Medical Incorporated
16.8. Ethicon, Inc.
16.9. GlaxoSmithKline plc
16.10. Integra LifeSciences Holdings Corporation
16.11. Johnson & Johnson
16.12. Kuros Biosciences AG
16.13. MicroPort Scientific Corporation
16.14. Novartis AG
16.15. Pfizer Inc.
16.16. Poly-Med, Inc.
16.17. Roche Holding AG
16.18. Smith & Nephew plc
16.19. Stryker Corporation
16.20. Synovis Micro Companies Alliance, Inc.
16.21. Teleflex Incorporated
16.22. Tepha, Inc.
16.23. Tigenix NV
16.24. Zimmer Biomet Holdings, Inc.
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Drug Eluting Sutures Market, Years Considered for the Study
FIGURE 2. Global Drug Eluting Sutures Market, Research Design
FIGURE 3. Global Drug Eluting Sutures Market, Research Framework
FIGURE 4. Global Drug Eluting Sutures Market, Data Triangulation
FIGURE 5. Global Drug Eluting Sutures Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Drug Eluting Sutures Market Size, by Drug Type, 2025 vs 2032 (%)
FIGURE 7. Global Drug Eluting Sutures Market Size, by Drug Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Drug Eluting Sutures Market Size, by Material, 2025 vs 2032 (%)
FIGURE 9. Global Drug Eluting Sutures Market Size, by Material, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Drug Eluting Sutures Market Size, by Application, 2025 vs 2032 (%)
FIGURE 11. Global Drug Eluting Sutures Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Drug Eluting Sutures Market Size, by End User, 2025 vs 2032 (%)
FIGURE 13. Global Drug Eluting Sutures Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Drug Eluting Sutures Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 15. Global Drug Eluting Sutures Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Drug Eluting Sutures Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Drug Eluting Sutures Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Drug Eluting Sutures Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Drug Eluting Sutures Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Drug Eluting Sutures Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Drug Eluting Sutures Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Drug Eluting Sutures Market Segmentation & Coverage
TABLE 2. Global Drug Eluting Sutures Market Size, 2017-2032 (USD Million)
TABLE 3. Global Drug Eluting Sutures Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 4. Global Anti-adhesion Eluting Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Anti-adhesion Eluting Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Anti-adhesion Eluting Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Anti-inflammatory Eluting Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Anti-inflammatory Eluting Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Anti-inflammatory Eluting Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Nsaid Coated Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Nsaid Coated Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Nsaid Coated Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Steroid Coated Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Steroid Coated Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Steroid Coated Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Antimicrobial Eluting Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Antimicrobial Eluting Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Antimicrobial Eluting Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Silver Coated Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Silver Coated Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Silver Coated Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Triclosan Coated Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Triclosan Coated Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Triclosan Coated Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Growth Factor Eluting Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Growth Factor Eluting Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Growth Factor Eluting Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Bmp Coated Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Bmp Coated Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Bmp Coated Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Vegf Coated Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Vegf Coated Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Vegf Coated Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Drug Eluting Sutures Market Size, by Material, 2017-2032 (USD Million)
TABLE 35. Global Natural Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global Natural Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global Natural Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global Catgut Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Catgut Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Catgut Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Silk Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Silk Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Silk Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Synthetic Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Synthetic Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Synthetic Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Poliglecaprone Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Poliglecaprone Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Poliglecaprone Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Polydioxanone Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Polydioxanone Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Polydioxanone Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Polyglactin Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Polyglactin Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Polyglactin Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Drug Eluting Sutures Market Size, by Application, 2017-2032 (USD Million)
TABLE 57. Global Cardiovascular Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Global Cardiovascular Market Size, by Group, 2017-2032 (USD Million)
TABLE 59. Global Cardiovascular Market Size, by Country, 2017-2032 (USD Million)
TABLE 60. Global Bypass Surgery Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Global Bypass Surgery Market Size, by Group, 2017-2032 (USD Million)
TABLE 62. Global Bypass Surgery Market Size, by Country, 2017-2032 (USD Million)
TABLE 63. Global Valve Repair Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Global Valve Repair Market Size, by Group, 2017-2032 (USD Million)
TABLE 65. Global Valve Repair Market Size, by Country, 2017-2032 (USD Million)
TABLE 66. Global General Surgery Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Global General Surgery Market Size, by Group, 2017-2032 (USD Million)
TABLE 68. Global General Surgery Market Size, by Country, 2017-2032 (USD Million)
TABLE 69. Global Abdominal Surgery Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. Global Abdominal Surgery Market Size, by Group, 2017-2032 (USD Million)
TABLE 71. Global Abdominal Surgery Market Size, by Country, 2017-2032 (USD Million)
TABLE 72. Global Plastic Surgery Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Global Plastic Surgery Market Size, by Group, 2017-2032 (USD Million)
TABLE 74. Global Plastic Surgery Market Size, by Country, 2017-2032 (USD Million)
TABLE 75. Global Urological Surgery Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Global Urological Surgery Market Size, by Group, 2017-2032 (USD Million)
TABLE 77. Global Urological Surgery Market Size, by Country, 2017-2032 (USD Million)
TABLE 78. Global Gynecology Market Size, by Region, 2017-2032 (USD Million)
TABLE 79. Global Gynecology Market Size, by Group, 2017-2032 (USD Million)
TABLE 80. Global Gynecology Market Size, by Country, 2017-2032 (USD Million)
TABLE 81. Global Ophthalmic Market Size, by Region, 2017-2032 (USD Million)
TABLE 82. Global Ophthalmic Market Size, by Group, 2017-2032 (USD Million)
TABLE 83. Global Ophthalmic Market Size, by Country, 2017-2032 (USD Million)
TABLE 84. Global Orthopedic Market Size, by Region, 2017-2032 (USD Million)
TABLE 85. Global Orthopedic Market Size, by Group, 2017-2032 (USD Million)
TABLE 86. Global Orthopedic Market Size, by Country, 2017-2032 (USD Million)
TABLE 87. Global Joint Reconstruction Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. Global Joint Reconstruction Market Size, by Group, 2017-2032 (USD Million)
TABLE 89. Global Joint Reconstruction Market Size, by Country, 2017-2032 (USD Million)
TABLE 90. Global Sports Medicine Market Size, by Region, 2017-2032 (USD Million)
TABLE 91. Global Sports Medicine Market Size, by Group, 2017-2032 (USD Million)
TABLE 92. Global Sports Medicine Market Size, by Country, 2017-2032 (USD Million)
TABLE 93. Global Drug Eluting Sutures Market Size, by End User, 2017-2032 (USD Million)
TABLE 94. Global Ambulatory Surgical Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 95. Global Ambulatory Surgical Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 96. Global Ambulatory Surgical Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 97. Global Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 98. Global Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 99. Global Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 100. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 101. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 102. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 103. Global Drug Eluting Sutures Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 104. Global Offline Market Size, by Region, 2017-2032 (USD Million)
TABLE 105. Global Offline Market Size, by Group, 2017-2032 (USD Million)
TABLE 106. Global Offline Market Size, by Country, 2017-2032 (USD Million)
TABLE 107. Global Online Market Size, by Region, 2017-2032 (USD Million)
TABLE 108. Global Online Market Size, by Group, 2017-2032 (USD Million)
TABLE 109. Global Online Market Size, by Country, 2017-2032 (USD Million)
TABLE 110. Global Drug Eluting Sutures Market Size, by Region, 2017-2032 (USD Million)
TABLE 111. Asia-Pacific Drug Eluting Sutures Market Size, by Region, 2017-2032 (USD Million)
TABLE 112. Asia-Pacific Drug Eluting Sutures Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 113. Asia-Pacific Drug Eluting Sutures Market Size, by Anti-inflammatory Eluting, 2017-2032 (USD Million)
TABLE 114. Asia-Pacific Drug Eluting Sutures Market Size, by Antimicrobial Eluting, 2017-2032 (USD Million)
TABLE 115. Asia-Pacific Drug Eluting Sutures Market Size, by Growth Factor Eluting, 2017-2032 (USD Million)
TABLE 116. Asia-Pacific Drug Eluting Sutures Market Size, by Material, 2017-2032 (USD Million)
TABLE 117. Asia-Pacific Drug Eluting Sutures Market Size, by Natural, 2017-2032 (USD Million)
TABLE 118. Asia-Pacific Drug Eluting Sutures Market Size, by Synthetic, 2017-2032 (USD Million)
TABLE 119. Asia-Pacific Drug Eluting Sutures Market Size, by Application, 2017-2032 (USD Million)
TABLE 120. Asia-Pacific Drug Eluting Sutures Market Size, by Cardiovascular, 2017-2032 (USD Million)
TABLE 121. Asia-Pacific Drug Eluting Sutures Market Size, by General Surgery, 2017-2032 (USD Million)
TABLE 122. Asia-Pacific Drug Eluting Sutures Market Size, by Orthopedic, 2017-2032 (USD Million)
TABLE 123. Asia-Pacific Drug Eluting Sutures Market Size, by End User, 2017-2032 (USD Million)
TABLE 124. Asia-Pacific Drug Eluting Sutures Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 125. North America Drug Eluting Sutures Market Size, by Region, 2017-2032 (USD Million)
TABLE 126. North America Drug Eluting Sutures Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 127. North America Drug Eluting Sutures Market Size, by Anti-inflammatory Eluting, 2017-2032 (USD Million)
TABLE 128. North America Drug Eluting Sutures Market Size, by Antimicrobial Eluting, 2017-2032 (USD Million)
TABLE 129. North America Drug Eluting Sutures Market Size, by Growth Factor Eluting, 2017-2032 (USD Million)
TABLE 130. North America Drug Eluting Sutures Market Size, by Material, 2017-2032 (USD Million)
TABLE 131. North America Drug Eluting Sutures Market Size, by Natural, 2017-2032 (USD Million)
TABLE 132. North America Drug Eluting Sutures Market Size, by Synthetic, 2017-2032 (USD Million)
TABLE 133. North America Drug Eluting Sutures Market Size, by Application, 2017-2032 (USD Million)
TABLE 134. North America Drug Eluting Sutures Market Size, by Cardiovascular, 2017-2032 (USD Million)
TABLE 135. North America Drug Eluting Sutures Market Size, by General Surgery, 2017-2032 (USD Million)
TABLE 136. North America Drug Eluting Sutures Market Size, by Orthopedic, 2017-2032 (USD Million)
TABLE 137. North America Drug Eluting Sutures Market Size, by End User, 2017-2032 (USD Million)
TABLE 138. North America Drug Eluting Sutures Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 139. Latin America Drug Eluting Sutures Market Size, by Region, 2017-2032 (USD Million)
TABLE 140. Latin America Drug Eluting Sutures Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 141. Latin America Drug Eluting Sutures Market Size, by Anti-inflammatory Eluting, 2017-2032 (USD Million)
TABLE 142. Latin America Drug Eluting Sutures Market Size, by Antimicrobial Eluting, 2017-2032 (USD Million)
TABLE 143. Latin America Drug Eluting Sutures Market Size, by Growth Factor Eluting, 2017-2032 (USD Million)
TABLE 144. Latin America Drug Eluting Sutures Market Size, by Material, 2017-2032 (USD Million)
TABLE 145. Latin America Drug Eluting Sutures Market Size, by Natural, 2017-2032 (USD Million)
TABLE 146. Latin America Drug Eluting Sutures Market Size, by Synthetic, 2017-2032 (USD Million)
TABLE 147. Latin America Drug Eluting Sutures Market Size, by Application, 2017-2032 (USD Million)
TABLE 148. Latin America Drug Eluting Sutures Market Size, by Cardiovascular, 2017-2032 (USD Million)
TABLE 149. Latin America Drug Eluting Sutures Market Size, by General Surgery, 2017-2032 (USD Million)
TABLE 150. Latin America Drug Eluting Sutures Market Size, by Orthopedic, 2017-2032 (USD Million)
TABLE 151. Latin America Drug Eluting Sutures Market Size, by End User, 2017-2032 (USD Million)
TABLE 152. Latin America Drug Eluting Sutures Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 153. Europe Drug Eluting Sutures Market Size, by Region, 2017-2032 (USD Million)
TABLE 154. Europe Drug Eluting Sutures Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 155. Europe Drug Eluting Sutures Market Size, by Anti-inflammatory Eluting, 2017-2032 (USD Million)
TABLE 156. Europe Drug Eluting Sutures Market Size, by Antimicrobial Eluting, 2017-2032 (USD Million)
TABLE 157. Europe Drug Eluting Sutures Market Size, by Growth Factor Eluting, 2017-2032 (USD Million)
TABLE 158. Europe Drug Eluting Sutures Market Size, by Material, 2017-2032 (USD Million)
TABLE 159. Europe Drug Eluting Sutures Market Size, by Natural, 2017-2032 (USD Million)
TABLE 160. Europe Drug Eluting Sutures Market Size, by Synthetic, 2017-2032 (USD Million)
TABLE 161. Europe Drug Eluting Sutures Market Size, by Application, 2017-2032 (USD Million)
TABLE 162. Europe Drug Eluting Sutures Market Size, by Cardiovascular, 2017-2032 (USD Million)
TABLE 163. Europe Drug Eluting Sutures Market Size, by General Surgery, 2017-2032 (USD Million)
TABLE 164. Europe Drug Eluting Sutures Market Size, by Orthopedic, 2017-2032 (USD Million)
TABLE 165. Europe Drug Eluting Sutures Market Size, by End User, 2017-2032 (USD Million)
TABLE 166. Europe Drug Eluting Sutures Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 167. Middle East Drug Eluting Sutures Market Size, by Region, 2017-2032 (USD Million)
TABLE 168. Middle East Drug Eluting Sutures Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 169. Middle East Drug Eluting Sutures Market Size, by Anti-inflammatory Eluting, 2017-2032 (USD Million)
TABLE 170. Middle East Drug Eluting Sutures Market Size, by Antimicrobial Eluting, 2017-2032 (USD Million)
TABLE 171. Middle East Drug Eluting Sutures Market Size, by Growth Factor Eluting, 2017-2032 (USD Million)
TABLE 172. Middle East Drug Eluting Sutures Market Size, by Material, 2017-2032 (USD Million)
TABLE 173. Middle East Drug Eluting Sutures Market Size, by Natural, 2017-2032 (USD Million)
TABLE 174. Middle East Drug Eluting Sutures Market Size, by Synthetic, 2017-2032 (USD Million)
TABLE 175. Middle East Drug Eluting Sutures Market Size, by Application, 2017-2032 (USD Million)
TABLE 176. Middle East Drug Eluting Sutures Market Size, by Cardiovascular, 2017-2032 (USD Million)
TABLE 177. Middle East Drug Eluting Sutures Market Size, by General Surgery, 2017-2032 (USD Million)
TABLE 178. Middle East Drug Eluting Sutures Market Size, by Orthopedic, 2017-2032 (USD Million)
TABLE 179. Middle East Drug Eluting Sutures Market Size, by End User, 2017-2032 (USD Million)
TABLE 180. Middle East Drug Eluting Sutures Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 181. Africa Drug Eluting Sutures Market Size, by Region, 2017-2032 (USD Million)
TABLE 182. Africa Drug Eluting Sutures Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 183. Africa Drug Eluting Sutures Market Size, by Anti-inflammatory Eluting, 2017-2032 (USD Million)
TABLE 184. Africa Drug Eluting Sutures Market Size, by Antimicrobial Eluting, 2017-2032 (USD Million)
TABLE 185. Africa Drug Eluting Sutures Market Size, by Growth Factor Eluting, 2017-2032 (USD Million)
TABLE 186. Africa Drug Eluting Sutures Market Size, by Material, 2017-2032 (USD Million)
TABLE 187. Africa Drug Eluting Sutures Market Size, by Natural, 2017-2032 (USD Million)
TABLE 188. Africa Drug Eluting Sutures Market Size, by Synthetic, 2017-2032 (USD Million)
TABLE 189. Africa Drug Eluting Sutures Market Size, by Application, 2017-2032 (USD Million)
TABLE 190. Africa Drug Eluting Sutures Market Size, by Cardiovascular, 2017-2032 (USD Million)
TABLE 191. Africa Drug Eluting Sutures Market Size, by General Surgery, 2017-2032 (USD Million)
TABLE 192. Africa Drug Eluting Sutures Market Size, by Orthopedic, 2017-2032 (USD Million)
TABLE 193. Africa Drug Eluting Sutures Market Size, by End User, 2017-2032 (USD Million)
TABLE 194. Africa Drug Eluting Sutures Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 195. Global Drug Eluting Sutures Market Size, by Group, 2017-2032 (USD Million)
TABLE 196. ASEAN Drug Eluting Sutures Market Size, by Group, 2017-2032 (USD Million)
TABLE 197. ASEAN Drug Eluting Sutures Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 198. ASEAN Drug Eluting Sutures Market Size, by Anti-inflammatory Eluting, 2017-2032 (USD Million)
TABLE 199. ASEAN Drug Eluting Sutures Market Size, by Antimicrobial Eluting, 2017-2032 (USD Million)
TABLE 200. ASEAN Drug Eluting Sutures Market Size, by Growth Factor Eluting, 2017-2032 (USD Million)
TABLE 201. ASEAN Drug Eluting Sutures Market Size, by Material, 2017-2032 (USD Million)
TABLE 202. ASEAN Drug Eluting Sutures Market Size, by Natural, 2017-2032 (USD Million)
TABLE 203. ASEAN Drug Eluting Sutures Market Size, by Synthetic, 2017-2032 (USD Million)
TABLE 204. ASEAN Drug Eluting Sutures Market Size, by Application, 2017-2032 (USD Million)
TABLE 205. ASEAN Drug Eluting Sutures Market Size, by Cardiovascular, 2017-2032 (USD Million)
TABLE 206. ASEAN Drug Eluting Sutures Market Size, by General Surgery, 2017-2032 (USD Million)
TABLE 207. ASEAN Drug Eluting Sutures Market Size, by Orthopedic, 2017-2032 (USD Million)
TABLE 208. ASEAN Drug Eluting Sutures Market Size, by End User, 2017-2032 (USD Million)
TABLE 209. ASEAN Drug Eluting Sutures Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 210. GCC Drug Eluting Sutures Market Size, by Group, 2017-2032 (USD Million)
TABLE 211. GCC Drug Eluting Sutures Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 212. GCC Drug Eluting Sutures Market Size, by Anti-inflammatory Eluting, 2017-2032 (USD Million)
TABLE 213. GCC Drug Eluting Sutures Market Size, by Antimicrobial Eluting, 2017-2032 (USD Million)
TABLE 214. GCC Drug Eluting Sutures Market Size, by Growth Factor Eluting, 2017-2032 (USD Million)
TABLE 215. GCC Drug Eluting Sutures Market Size, by Material, 2017-2032 (USD Million)
TABLE 216. GCC Drug Eluting Sutures Market Size, by Natural, 2017-2032 (USD Million)
TABLE 217. GCC Drug Eluting Sutures Market Size, by Synthetic, 2017-2032 (USD Million)
TABLE 218. GCC Drug Eluting Sutures Market Size, by Application, 2017-2032 (USD Million)
TABLE 219. GCC Drug Eluting Sutures Market Size, by Cardiovascular, 2017-2032 (USD Million)
TABLE 220. GCC Drug Eluting Sutures Market Size, by General Surgery, 2017-2032 (USD Million)
TABLE 221. GCC Drug Eluting Sutures Market Size, by Orthopedic, 2017-2032 (USD Million)
TABLE 222. GCC Drug Eluting Sutures Market Size, by End User, 2017-2032 (USD Million)
TABLE 223. GCC Drug Eluting Sutures Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 224. European Union Drug Eluting Sutures Market Size, by Group, 2017-2032 (USD Million)
TABLE 225. European Union Drug Eluting Sutures Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 226. European Union Drug Eluting Sutures Market Size, by Anti-inflammatory Eluting, 2017-2032 (USD Million)
TABLE 227. European Union Drug Eluting Sutures Market Size, by Antimicrobial Eluting, 2017-2032 (USD Million)
TABLE 228. European Union Drug Eluting Sutures Market Size, by Growth Factor Eluting, 2017-2032 (USD Million)
TABLE 229. European Union Drug Eluting Sutures Market Size, by Material, 2017-2032 (USD Million)
TABLE 230. European Union Drug Eluting Sutures Market Size, by Natural, 2017-2032 (USD Million)
TABLE 231. European Union Drug Eluting Sutures Market Size, by Synthetic, 2017-2032 (USD Million)
TABLE 232. European Union Drug Eluting Sutures Market Size, by Application, 2017-2032 (USD Million)
TABLE 233. European Union Drug Eluting Sutures Market Size, by Cardiovascular, 2017-2032 (USD Million)
TABLE 234. European Union Drug Eluting Sutures Market Size, by General Surgery, 2017-2032 (USD Million)
TABLE 235. European Union Drug Eluting Sutures Market Size, by Orthopedic, 2017-2032 (USD Million)
TABLE 236. European Union Drug Eluting Sutures Market Size, by End User, 2017-2032 (USD Million)
TABLE 237. European Union Drug Eluting Sutures Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 238. BRICS Drug Eluting Sutures Market Size, by Group, 2017-2032 (USD Million)
TABLE 239. BRICS Drug Eluting Sutures Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 240. BRICS Drug Eluting Sutures Market Size, by Anti-inflammatory Eluting, 2017-2032 (USD Million)
TABLE 241. BRICS Drug Eluting Sutures Market Size, by Antimicrobial Eluting, 2017-2032 (USD Million)
TABLE 242. BRICS Drug Eluting Sutures Market Size, by Growth Factor Eluting, 2017-2032 (USD Million)
TABLE 243. BRICS Drug Eluting Sutures Market Size, by Material, 2017-2032 (USD Million)
TABLE 244. BRICS Drug Eluting Sutures Market Size, by Natural, 2017-2032 (USD Million)
TABLE 245. BRICS Drug Eluting Sutures Market Size, by Synthetic, 2017-2032 (USD Million)
TABLE 246. BRICS Drug Eluting Sutures Market Size, by Application, 2017-2032 (USD Million)
TABLE 247. BRICS Drug Eluting Sutures Market Size, by Cardiovascular, 2017-2032 (USD Million)
TABLE 248. BRICS Drug Eluting Sutures Market Size, by General Surgery, 2017-2032 (USD Million)
TABLE 249. BRICS Drug Eluting Sutures Market Size, by Orthopedic, 2017-2032 (USD Million)
TABLE 250. BRICS Drug Eluting Sutures Market Size, by End User, 2017-2032 (USD Million)
TABLE 251. BRICS Drug Eluting Sutures Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 252. G7 Drug Eluting Sutures Market Size, by Group, 2017-2032 (USD Million)
TABLE 253. G7 Drug Eluting Sutures Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 254. G7 Drug Eluting Sutures Market Size, by Anti-inflammatory Eluting, 2017-2032 (USD Million)
TABLE 255. G7 Drug Eluting Sutures Market Size, by Antimicrobial Eluting, 2017-2032 (USD Million)
TABLE 256. G7 Drug Eluting Sutures Market Size, by Growth Factor Eluting, 2017-2032 (USD Million)
TABLE 257. G7 Drug Eluting Sutures Market Size, by Material, 2017-2032 (USD Million)
TABLE 258. G7 Drug Eluting Sutures Market Size, by Natural, 2017-2032 (USD Million)
TABLE 259. G7 Drug Eluting Sutures Market Size, by Synthetic, 2017-2032 (USD Million)
TABLE 260. G7 Drug Eluting Sutures Market Size, by Application, 2017-2032 (USD Million)
TABLE 261. G7 Drug Eluting Sutures Market Size, by Cardiovascular, 2017-2032 (USD Million)
TABLE 262. G7 Drug Eluting Sutures Market Size, by General Surgery, 2017-2032 (USD Million)
TABLE 263. G7 Drug Eluting Sutures Market Size, by Orthopedic, 2017-2032 (USD Million)
TABLE 264. G7 Drug Eluting Sutures Market Size, by End User, 2017-2032 (USD Million)
TABLE 265. G7 Drug Eluting Sutures Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 266. NATO Drug Eluting Sutures Market Size, by Group, 2017-2032 (USD Million)
TABLE 267. NATO Drug Eluting Sutures Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 268. NATO Drug Eluting Sutures Market Size, by Anti-inflammatory Eluting, 2017-2032 (USD Million)
TABLE 269. NATO Drug Eluting Sutures Market Size, by Antimicrobial Eluting, 2017-2032 (USD Million)
TABLE 270. NATO Drug Eluting Sutures Market Size, by Growth Factor Eluting, 2017-2032 (USD Million)
TABLE 271. NATO Drug Eluting Sutures Market Size, by Material, 2017-2032 (USD Million)
TABLE 272. NATO Drug Eluting Sutures Market Size, by Natural, 2017-2032 (USD Million)
TABLE 273. NATO Drug Eluting Sutures Market Size, by Synthetic, 2017-2032 (USD Million)
TABLE 274. NATO Drug Eluting Sutures Market Size, by Application, 2017-2032 (USD Million)
TABLE 275. NATO Drug Eluting Sutures Market Size, by Cardiovascular, 2017-2032 (USD Million)
TABLE 276. NATO Drug Eluting Sutures Market Size, by General Surgery, 2017-2032 (USD Million)
TABLE 277. NATO Drug Eluting Sutures Market Size, by Orthopedic, 2017-2032 (USD Million)
TABLE 278. NATO Drug Eluting Sutures Market Size, by End User, 2017-2032 (USD Million)
TABLE 279. NATO Drug Eluting Sutures Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 280. Global Drug Eluting Sutures Market Size, by Country, 2017-2032 (USD Million)
TABLE 281. United States Drug Eluting Sutures Market Size, 2017-2032 (USD Million)
TABLE 282. United States Drug Eluting Sutures Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 283. United States Drug Eluting Sutures Market Size, by Anti-inflammatory Eluting, 2017-2032 (USD Million)
TABLE 284. United States Drug Eluting Sutures Market Size, by Antimicrobial Eluting, 2017-2032 (USD Million)
TABLE 285. United States Drug Eluting Sutures Market Size, by Growth Factor Eluting, 2017-2032 (USD Million)
TABLE 286. United States Drug Eluting Sutures Market Size, by Material, 2017-2032 (USD Million)
TABLE 287. United States Drug Eluting Sutures Market Size, by Natural, 2017-2032 (USD Million)
TABLE 288. United States Drug Eluting Sutures Market Size, by Synthetic, 2017-2032 (USD Million)
TABLE 289. United States Drug Eluting Sutures Market Size, by Application, 2017-2032 (USD Million)
TABLE 290. United States Drug Eluting Sutures Market Size, by Cardiovascular, 2017-2032 (USD Million)
TABLE 291. United States Drug Eluting Sutures Market Size, by General Surgery, 2017-2032 (USD Million)
TABLE 292. United States Drug Eluting Sutures Market Size, by Orthopedic, 2017-2032 (USD Million)
TABLE 293. United States Drug Eluting Sutures Market Size, by End User, 2017-2032 (USD Million)
TABLE 294. United States Drug Eluting Sutures Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 295. Canada Drug Eluting Sutures Market Size, 2017-2032 (USD Million)
TABLE 296. Canada Drug Eluting Sutures Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 297. Canada Drug Eluting Sutures Market Size, by Anti-inflammatory Eluting, 2017-2032 (USD Million)
TABLE 298. Canada Drug Eluting Sutures Market Size, by Antimicrobial Eluting, 2017-2032 (USD Million)
TABLE 299. Canada Drug Eluting Sutures Market Size, by Growth Factor Eluting, 2017-2032 (USD Million)
TABLE 300. Canada Drug Eluting Sutures Market Size, by Material, 2017-2032 (USD Million)
TABLE 301. Canada Drug Eluting Sutures Market Size, by Natural, 2017-2032 (USD Million)
TABLE 302. Canada Drug Eluting Sutures Market Size, by Synthetic, 2017-2032 (USD Million)
TABLE 303. Canada Drug Eluting Sutures Market Size, by Application, 2017-2032 (USD Million)
TABLE 304. Canada Drug Eluting Sutures Market Size, by Cardiovascular, 2017-2032 (USD Million)
TABLE 305. Canada Drug Eluting Sutures Market Size, by General Surgery, 2017-2032 (USD Million)
TABLE 306. Canada Drug Eluting Sutures Market Size, by Orthopedic, 2017-2032 (USD Million)
TABLE 307. Canada Drug Eluting Sutures Market Size, by End User, 2017-2032 (USD Million)
TABLE 308. Canada Drug Eluting Sutures Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 309. Mexico Drug Eluting Sutures Market Size, 2017-2032 (USD Million)
TABLE 310. Mexico Drug Eluting Sutures Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 311. Mexico Drug Eluting Sutures Market Size, by Anti-inflammatory Eluting, 2017-2032 (USD Million)
TABLE 312. Mexico Drug Eluting Sutures Market Size, by Antimicrobial Eluting, 2017-2032 (USD Million)
TABLE 313. Mexico Drug Eluting Sutures Market Size, by Growth Factor Eluting, 2017-2032 (USD Million)
TABLE 314. Mexico Drug Eluting Sutures Market Size, by Material, 2017-2032 (USD Million)
TABLE 315. Mexico Drug Eluting Sutures Market Size, by Natural, 2017-2032 (USD Million)
TABLE 316. Mexico Drug Eluting Sutures Market Size, by Synthetic, 2017-2032 (USD Million)
TABLE 317. Mexico Drug Eluting Sutures Market Size, by Application, 2017-2032 (USD Million)
TABLE 318. Mexico Drug Eluting Sutures Market Size, by Cardiovascular, 2017-2032 (USD Million)
TABLE 319. Mexico Drug Eluting Sutures Market Size, by General Surgery, 2017-2032 (USD Million)
TABLE 320. Mexico Drug Eluting Sutures Market Size, by Orthopedic, 2017-2032 (USD Million)
TABLE 321. Mexico Drug Eluting Sutures Market Size, by End User, 2017-2032 (USD Million)
TABLE 322. Mexico Drug Eluting Sutures Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 323. Brazil Drug Eluting Sutures Market Size, 2017-2032 (USD Million)
TABLE 324. Brazil Drug Eluting Sutures Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 325. Brazil Drug Eluting Sutures Market Size, by Anti-inflammatory Eluting, 2017-2032 (USD Million)
TABLE 326. Brazil Drug Eluting Sutures Market Size, by Antimicrobial Eluting, 2017-2032 (USD Million)
TABLE 327. Brazil Drug Eluting Sutures Market Size, by Growth Factor Eluting, 2017-2032 (USD Million)
TABLE 328. Brazil Drug Eluting Sutures Market Size, by Material, 2017-2032 (USD Million)
TABLE 329. Brazil Drug Eluting Sutures Market Size, by Natural, 2017-2032 (USD Million)
TABLE 330. Brazil Drug Eluting Sutures Market Size, by Synthetic, 2017-2032 (USD Million)
TABLE 331. Brazil Drug Eluting Sutures Market Size, by Application, 2017-2032 (USD Million)
TABLE 332. Brazil Drug Eluting Sutures Market Size, by Cardiovascular, 2017-2032 (USD Million)
TABLE 333. Brazil Drug Eluting Sutures Market Size, by General Surgery, 2017-2032 (USD Million)
TABLE 334. Brazil Drug Eluting Sutures Market Size, by Orthopedic, 2017-2032 (USD Million)
TABLE 335. Brazil Drug Eluting Sutures Market Size, by End User, 2017-2032 (USD Million)
TABLE 336. Brazil Drug Eluting Sutures Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 337. United Kingdom Drug Eluting Sutures Market Size, 2017-2032 (USD Million)
TABLE 338. United Kingdom Drug Eluting Sutures Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 339. United Kingdom Drug Eluting Sutures Market Size, by Anti-inflammatory Eluting, 2017-2032 (USD Million)
TABLE 340. United Kingdom Drug Eluting Sutures Market Size, by Antimicrobial Eluting, 2017-2032 (USD Million)
TABLE 341. United Kingdom Drug Eluting Sutures Market Size, by Growth Factor Eluting, 2017-2032 (USD Million)
TABLE 342. United Kingdom Drug Eluting Sutures Market Size, by Material, 2017-2032 (USD Million)
TABLE 343. United Kingdom Drug Eluting Sutures Market Size, by Natural, 2017-2032 (USD Million)
TABLE 344. United Kingdom Drug Eluting Sutures Market Size, by Synthetic, 2017-2032 (USD Million)
TABLE 345. United Kingdom Drug Eluting Sutures Market Size, by Application, 2017-2032 (USD Million)
TABLE 346. United Kingdom Drug Eluting Sutures Market Size, by Cardiovascular, 2017-2032 (USD Million)
TABLE 347. United Kingdom Drug Eluting Sutures Market Size, by General Surgery, 2017-2032 (USD Million)
TABLE 348. United Kingdom Drug Eluting Sutures Market Size, by Orthopedic, 2017-2032 (USD Million)
TABLE 349. United Kingdom Drug Eluting Sutures Market Size, by End User, 2017-2032 (USD Million)
TABLE 350. United Kingdom Drug Eluting Sutures Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 351. Germany Drug Eluting Sutures Market Size, 2017-2032 (USD Million)
TABLE 352. Germany Drug Eluting Sutures Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 353. Germany Drug Eluting Sutures Market Size, by Anti-inflammatory Eluting, 2017-2032 (USD Million)
TABLE 354. Germany Drug Eluting Sutures Market Size, by Antimicrobial Eluting, 2017-2032 (USD Million)
TABLE 355. Germany Drug Eluting Sutures Market Size, by Growth Factor Eluting, 2017-2032 (USD Million)
TABLE 356. Germany Drug Eluting Sutures Market Size, by Material, 2017-2032 (USD Million)
TABLE 357. Germany Drug Eluting Sutures Market Size, by Natural, 2017-2032 (USD Million)
TABLE 358. Germany Drug Eluting Sutures Market Size, by Synthetic, 2017-2032 (USD Million)
TABLE 359. Germany Drug Eluting Sutures Market Size, by Application, 2017-2032 (USD Million)
TABLE 360. Germany Drug Eluting Sutures Market Size, by Cardiovascular, 2017-2032 (USD Million)
TABLE

Companies Mentioned

  • Aesculap AG
  • Allergan plc
  • AstraZeneca PLC
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Conmed Corporation
  • Cook Medical Incorporated
  • Ethicon, Inc.
  • GlaxoSmithKline plc
  • Integra LifeSciences Holdings Corporation
  • Johnson & Johnson
  • Kuros Biosciences AG
  • MicroPort Scientific Corporation
  • Novartis AG
  • Pfizer Inc.
  • Poly-Med, Inc.
  • Roche Holding AG
  • Smith & Nephew plc
  • Stryker Corporation
  • Synovis Micro Companies Alliance, Inc.
  • Teleflex Incorporated
  • Tepha, Inc.
  • Tigenix NV
  • Zimmer Biomet Holdings, Inc.

Related Topics

Related Reports

Smart Sutures Market - Global Forecast 2026-2032 - Product Image

Smart Sutures Market - Global Forecast 2026-2032

  • Report
  • 182 Pages
  • Global
From
Antimicrobial Sutures - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Antimicrobial Sutures - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 180 Pages
  • Global
From
Ophthalmic Sutures Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026-2035 - Product Image

Ophthalmic Sutures Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026-2035

  • Report
  • 160 Pages
  • Global
From
Surgical Suture Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Surgical Suture Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Cardiac Sutures Market Outlook 2025-2034: Market Share, and Growth Analysis - Product Image

Cardiac Sutures Market Outlook 2025-2034: Market Share, and Growth Analysis

  • Report
  • 160 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.